111 related articles for article (PubMed ID: 12473871)
1. Factors influencing acute ischaemia-induced renal hypertension in rats.
Recordati G; Zorzoli F; Pontara O; Turolo L; Zanchetti A
J Hypertens; 2002 Dec; 20(12):2453-63. PubMed ID: 12473871
[TBL] [Abstract][Full Text] [Related]
2. Effects of a reversible 'nephrectomy' on renal sympathetic activity and blood pressure in the rat: evidence for an acute angiotensin-mediated hypertension.
Recordati G; Zorzoli F; Zanchetti A
J Hypertens; 2000 Sep; 18(9):1277-87. PubMed ID: 10994759
[TBL] [Abstract][Full Text] [Related]
3. Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects.
Schmitt F; Martinez F; Brillet G; Nguyen-Khoa T; Brouard R; Sissmann J; Lacour B; Grunfeld JP
J Cardiovasc Pharmacol; 1998 Feb; 31(2):314-21. PubMed ID: 9475275
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
Leenen FH; Yuan B
Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
[TBL] [Abstract][Full Text] [Related]
5. Irbesartan and emodin on myocardial remodeling in Goldblatt hypertensive rats.
Chen C; Liang Z; Chen Q; Li ZG
J Cardiovasc Pharmacol; 2012 Oct; 60(4):375-80. PubMed ID: 23064242
[TBL] [Abstract][Full Text] [Related]
6. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
[TBL] [Abstract][Full Text] [Related]
7. Control of hypertension with captopril affords better renal protection as compared with irbesartan in salt-loaded uremic rats.
Weissgarten J; Berman S; Efrati S; Rapoport M; Modai D; Cohn M; Aladjem M; Galperin E; Averbukh Z
Nephron Physiol; 2005; 101(1):p14-20. PubMed ID: 15925907
[TBL] [Abstract][Full Text] [Related]
8. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects.
Burnier M; Hagman M; Nussberger J; Biollaz J; Armagnac C; Brouard R; Weber B; Brunner HR
Hypertension; 1995 Apr; 25(4 Pt 1):602-9. PubMed ID: 7721404
[TBL] [Abstract][Full Text] [Related]
9. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D
Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170
[TBL] [Abstract][Full Text] [Related]
11. Impact of the renin-angiotensin system on cerebral perfusion following subarachnoid haemorrhage in the rat.
Fassot C; Lambert G; Elghozi JL; Lambert E
J Physiol; 2001 Sep; 535(Pt 2):533-40. PubMed ID: 11533142
[TBL] [Abstract][Full Text] [Related]
12. AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat.
Wilcox CS; Cardozo J; Welch WJ
Am J Physiol; 1996 Oct; 271(4 Pt 2):R891-6. PubMed ID: 8897978
[TBL] [Abstract][Full Text] [Related]
13. Influence of irbesartan and enalapril on changes of renal function associated with the established phase of l-NAME hypertension.
Jover B; Herizi A; Casellas D; Mimran A
J Hypertens; 2001 Nov; 19(11):2039-46. PubMed ID: 11677370
[TBL] [Abstract][Full Text] [Related]
14. Progressive renal insufficiency induces increasing protection against ischemic acute renal failure.
Zager RA; Baltes LA
J Lab Clin Med; 1984 Apr; 103(4):511-23. PubMed ID: 6699471
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic response to saline load in one-kidney/one-clip hypertensive rats.
Mac Laughlin M; Altenberg G; Gioioso E; Amorena CE; Taquini AC
Ren Physiol Biochem; 1990; 13(4):200-5. PubMed ID: 1691860
[TBL] [Abstract][Full Text] [Related]
17. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
Fridman K; Andersson OK; Wysocki M; Friberg P; Sunzel M
Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
[TBL] [Abstract][Full Text] [Related]
18. Losartan prevents salt-induced hypertension in reduced renal mass rats.
Kanagy NL; Fink GD
J Pharmacol Exp Ther; 1993 Jun; 265(3):1131-6. PubMed ID: 8509998
[TBL] [Abstract][Full Text] [Related]
19. Effect of DOCA-salt on angiotensin dependency and surgical reversal of hypertension in two-kidney, one clip renal hypertensive rats.
Takata Y; Doyle AE
J Hypertens; 1983 Jun; 1(1):57-63. PubMed ID: 6397514
[TBL] [Abstract][Full Text] [Related]
20. Failure of angiotensin II to suppress plasma renin activity in normotensive subjects with a positive family history of hypertension.
Herlitz H; Palmgren E; Widgren B; Aurell M
Clin Sci (Lond); 2005 Sep; 109(3):311-7. PubMed ID: 15901242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
